Autor según el artículo: Mérida, DM; Moreno-Franco, B; Marquès, M; León-Latre, M; Laclaustra, M; Guallar-Castillón, P
Departamento: Ciències Mèdiques Bàsiques
Autor/es de la URV: Marquès Bueno, Montserrat
Palabras clave: Phthalates Metabolic syndrome Meta-analysis
Resumen: Phthalates are chemicals widely used in plastic-based consumer products, and human exposure is universal. They are classified as endocrine disruptors, and specific phthalate metabolites have been associated with an increased risk of cardiometabolic diseases. The aim of this study was to assess the association between phthalate exposure and the metabolic syndrome in the general population. A comprehensive literature search was performed in four databases (Web of Science, Medline, PubMed, and Scopus). We included all the observational studies that evaluate the association between phthalate metabolites and the metabolic syndrome available until January 31st, 2023. Pooled Odds Ratios (OR) and their 95% confidence intervals were calculated by using the inverse-variance weighted method. Nine cross-sectional studies and 25,365 participants aged from 12 to 80 were included. Comparing extreme categories of phthalate exposure, the pooled ORs for the metabolic syndrome were: 1.08 (95% CI, 1.02-1.16, I2 = 28%) for low molecular weight phthalates, and 1.11 (95% CI, 1.07-1.16, I2 = 7%) for high molecular weight phthalates. For individual phthalate metabolites, the pooled ORs that achieved statistical significance were: 1.13 (95% CI, 1.00-1.27, I2 = 24%) for MiBP; 1.89 (95% CI, 1.17-3.07, I2 = 15%) for MMP in men; 1.12 (95% CI, 1.00-1.25, I2 = 22%) for MCOP; 1.09 (95% CI, 0.99-1.20, I2 = 0%) for MCPP; 1.16 (95% CI, 1.05-1.28, I2 = 6%) for MBzP; and 1.16 (95% CI, 1.09-1.24, I2 = 14%) for DEHP (including ΣDEHP and its metabolites). In conclusion, both low molecular weight and high molecular weight phthalates were associated with an 8 and 11% higher prevalence of the MetS, respectively. The exposure to six specific phthalate metabolites was associated with a higher prevalence of the MetS.Copyright © 2023. Published by Elsevier Ltd.
Áreas temáticas: Zootecnia / recursos pesqueiros Toxicology Saúde coletiva Química Pollution Nutrição Medicine (miscellaneous) Medicina ii Medicina i Matemática / probabilidade e estatística Interdisciplinar Health, toxicology and mutagenesis Geografía Geociências General medicine Farmacia Environmental sciences Ensino Engenharias iii Engenharias ii Engenharias i Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Ciência de alimentos Biotecnología Biodiversidade Arquitetura e urbanismo
Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
Direcció de correo del autor: montserrat.marques@urv.cat
Identificador del autor: 0000-0001-6302-8578
Fecha de alta del registro: 2024-08-03
Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
Enlace a la fuente original: https://www.sciencedirect.com/science/article/pii/S0269749123009594?via%3Dihub
URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
Referencia al articulo segun fuente origial: Environmental Pollution. 333 121957-121957
Referencia de l'ítem segons les normes APA: Mérida, DM; Moreno-Franco, B; Marquès, M; León-Latre, M; Laclaustra, M; Guallar-Castillón, P (2023). Phthalate exposure and the metabolic syndrome: A systematic review and meta-analysis. Environmental Pollution, 333(), 121957-121957. DOI: 10.1016/j.envpol.2023.121957
DOI del artículo: 10.1016/j.envpol.2023.121957
Entidad: Universitat Rovira i Virgili
Año de publicación de la revista: 2023
Tipo de publicación: Journal Publications
Repositori URV